Early research (Phase 1)Study completedNCT03821233What this trial is testingA Dose Finding Study of ZW49 in Patients With HER2-Positive CancersWho this might be right forHER2-expressing Cancers Zymeworks BC Inc. 112
Testing effectiveness (Phase 2)Study completedNCT05185947What this trial is testingIntravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal CarcinomatosisWho this might be right forGynecologic CancerGynecologic NeoplasmsPeritoneal Carcinomatosis+9 more National Cancer Institute (NCI) 21
Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06835179What this trial is testingSBRT Combined With CAPEOX, Bevacizumab, and PD-1 Inhibitor for the Treatment of RAS-Mutant, MSS-Type, Unresectable Metastatic Colorectal Cancer.Who this might be right forUnresectable Metastatic Colorectal CancerMicrosatellite Stable (MSS) Colorectal Cancer (CRC)RAS-mutant Colorectal Cancer The First Affiliated Hospital with Nanjing Medical University 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT06107413What this trial is testingStudy to Assess Adverse Events and Change in Disease Activity in Previously Treated Adult Participants Receiving Intravenous (IV) ABBV-400 With Unresectable Metastatic Colorectal Cancer in Combination With IV Fluorouracil, Folinic Acid, and BevacizumabWho this might be right forUnresectable Metastatic Colorectal Cancer AbbVie 280
Early research (Phase 1)Study completedNCT00005860What this trial is testingOxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the PeritoneumWho this might be right forCancer Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)UnknownNCT06485713What this trial is testingEfficacy and Safety of Trifluridine/Tipiracil Combined With Fufuquitinib for Third-line Treatment of mCRCWho this might be right forMetastatic Colorectal CancerDrug Therapy First Affiliated Hospital of Wenzhou Medical University 200
Testing effectiveness (Phase 2)Looking for participantsNCT07488676What this trial is testingASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid TumorsWho this might be right forGastric or Gastro-esophageal Junction (GEJ) AdenocarcinomaPancreatic Adenocarcinoma Astellas Pharma Global Development, Inc. 150
Testing effectiveness (Phase 2)Ended earlyNCT02842125What this trial is testingSafety and Efficacy of Intra-Arterial and Intra-Tumoral Ad-p53 With Capecitabine (Xeloda) or Anti-PD-1 in Liver Metastases of Solid Tumors and Recurrent Head and Neck Squamous Cell CancerWho this might be right forMetastatic Solid Tumor CancerRecurrent Head and Neck Cancer MultiVir, Inc. 4
Early research (Phase 1)Ended earlyNCT06364696What this trial is testingFind a Suitable Dose of ASP4396 in Adults With Solid TumorsWho this might be right forSolid Tumor Astellas Pharma Inc 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT07512674What this trial is testingModified Short-Course Radiotherapy Combined With Immunochemotherapy and Targeted Therapy as First-Line Treatment for MSS Metastatic Colorectal CancerWho this might be right forPatients With Initially Unresectable MSS-type Advanced Colorectal Cancer With Liver and/or Lung and Peritoneal Metastasis Sir Run Run Shaw Hospital 33
Large-scale testing (Phase 3)Looking for participantsNCT05863195What this trial is testingTesting Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP TrialWho this might be right forMetastatic Colorectal CarcinomaMetastatic Malignant Neoplasm in the LiverStage IV Colorectal Cancer AJCC v8+1 more ECOG-ACRIN Cancer Research Group 408
Large-scale testing (Phase 3)Active Not RecruitingNCT04230187What this trial is testingBevacizumab Plus mFOLFOXIRI as First-line Treatment for Patients With Unresectable Metastatic Colorectal CancerWho this might be right forColorectal Cancer Yanhong Deng 528
Early research (Phase 1)Looking for participantsNCT04991948What this trial is testingStudy of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal CancerWho this might be right forUnresectable Metastatic Colorectal Cancer Celyad Oncology SA 34
Testing effectiveness (Phase 2)UnknownNCT03022734What this trial is testingShort Course Radiotherapy, Unresectable Rectal Cancer, Liver MetastasisWho this might be right forRectal Cancer, Metastatic Yonsei University 40
Testing effectiveness (Phase 2)Looking for participantsNCT03965234What this trial is testingPulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal MetastasesWho this might be right forMetastatic Bone SarcomaMetastatic Malignant Neoplasm in the LungMetastatic Soft Tissue Sarcoma+3 more Roswell Park Cancer Institute 99
Testing effectiveness (Phase 2)WithdrawnNCT05518032What this trial is testingPembrolizumab and Autologous Dendritic Cells for the Treatment of Refractory Colorectal Cancer (CRC)Who this might be right forMetastatic Microsatellite Stable Colorectal CarcinomaRecurrent Colorectal CarcinomaStage III Colorectal Cancer AJCC v8+2 more Roswell Park Cancer Institute
Testing effectiveness (Phase 2)UnknownNCT04096417What this trial is testingPemigatinib for the Treatment of Metastatic or Unresectable Colorectal Cancer Harboring FGFR AlterationsWho this might be right forFGFR1 Gene AmplificationFGFR1 Gene MutationFGFR1 Gene Translocation+16 more Academic and Community Cancer Research United 14
Testing effectiveness (Phase 2)Ended earlyNCT01759238What this trial is testingChemoradiotherapy for Patients With Oligometastatic Colorectal CancerWho this might be right forColorectal CancerMetastases Universitätsklinikum Hamburg-Eppendorf 1
Testing effectiveness (Phase 2)Looking for participantsNCT06176885What this trial is testingEfficacy and Safety of Combined With Immunotherapy After Induction Therapy With Chemotherapy and Targeted Therapy in the First-line Treatment of Microsatellite Stable (MSS) Initially Unresectable Metastatic Colorectal CancerWho this might be right forColorectal Cancer yue junhan 36